Albemarle Corp buy Truist Financial Co.
Start price
21.01.26
/
50%
€150.94
Target price
21.01.27
€174.78
Performance (%)
-23.35%
Price
17.08.26
€115.70
Summary
This prediction is currently active. The prediction for Albemarle Corp disappoints with a performance of -23.35%. This prediction currently runs until 21.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | 1.714% | 1.714% |
| iShares Core DAX® | -0,05 % | 5,96 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % |
| iShares S&P 500 | -0,36 % | 2,75 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $205.00 price target on the stock, up previously from $125.00.
Ratings data for ALB provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Albemarle Corp
Albemarle Corp
Start price
Target price
Perf. (%)
€170.00
22.04.26
22.04.26
€208.62
22.04.27
22.04.27
-31.94%
17.08.26
17.08.26
